Astrocytic Activation Completely Corrects Memory Performance in an Alzheimer’s Disease Model
Authors:
- Tirzah KreiselTKTirzah Kreisel
- Yaara WeinsteinYWYaara Weinstein
- Maya GroysmanMGMaya Groysman
- Adi DoronADAdi Doron
- Ron RefaeliRRRon Refaeli
- Mickey LondonMLMickey London
- Inbal GoshenIGInbal Goshen
Preprint
Abstract
Neural and glial dysfunction are thought to underlie memory impairments in Alzheimer’s disease (AD). Conversely, astrocytes are known to play a central role in the healthy brain, and their activation has been shown to enhance memory. To test whether activation of astrocytes can correct memory deficits associated with AD, we expressed hM3Dq in CA1 astrocytes of 7 months old 5XFAD AD model mice, enabling astrocytic chemogenetic Gq pathway activation, following exposure to CNO. We report that astrocytic activation results in complete memory correction, and even memory improvement of AD model mice beyond that of untreated WT levels. We went further to discover the mechanisms underlying this memory improvement in AD mice: First, using 2-photon imaging and electrophysiology, we observed increased neuronal activity (displayed as elevated cFos expression and amplified awake Ca 2+ events) as well as augmented in-vivo long term plasticity following astrocytic activation. Subsequently, we observed increased astrocytic endocytosis of Aβ plaques. Finally, we report that the beneficial effects of astrocytic activation remained stable for an entire year, and persisted beyond the window of astrocytic Gq activation. Our findings that astrocytes correct memory impairments in an AD model could have important clinical implications towards treating this disease.Keywords
Funding Information
- European Research Council (101087731)
This publication has 64 references indexed in Scilit:
- Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic‐regulated connectivity and driving neuroinflammation in an Alzheimer's disease mouse modelAlzheimer's & Dementia, 2025
- Astrocyte‐neuronal network interplay is disrupted in Alzheimer's disease miceGlia, 2021
- 2021 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2021
- Limiting RyR2 Open Time Prevents Alzheimer’s Disease-Related Neuronal Hyperactivity and Memory Loss but Not β-Amyloid AccumulationCell Reports, 2020
- Gi/o protein‐coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmissionGlia, 2019
- Melanopsin for precise optogenetic activation of astrocyte‐neuron networksGlia, 2019
- Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory EnhancementCell, 2018
- Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's diseaseGlia, 2017
- Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease miceHippocampus, 2017
- Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortexActa Neuropathologica, 2000